Innovative Approaches to Stone Disease

Innovative approaches to managing stone disease are enhancing treatment options and improving patient outcomes. Advances in technology and surgical techniques have revolutionized the management of urinary stones, making procedures less invasive and more effective. Extracorporeal shock wave lithotripsy (ESWL) remains a popular non-invasive option, using sound waves to fragment stones for easier passage. However, for larger or complex stones, ureterostomy with laser lithotripsy is increasingly favoured, allowing for direct visualization and removal of stones with minimal recovery time. Recent innovations also include percutaneous which is particularly effective for large renal stones. Emerging technologies, such as flexible ureterostomy and robotic assistance, further enhance precision and success rates. Additionally, a greater understanding of the metabolic factors contributing to stone formation has led to individualized prevention strategies, including dietary modifications and pharmacotherapy aimed at reducing stone recurrence. Education on lifestyle changes, such as increased hydration and dietary adjustments, plays a crucial role in long-term management. As research continues, innovative techniques and a holistic approach will further advance the field of stone disease management.

    Related Conference of Innovative Approaches to Stone Disease

    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    November 03-04, 2025

    29th European Nephrology Conference

    Rome, Italy
    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    Innovative Approaches to Stone Disease Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in